Petrus S. Steyn

TL;DR: A randomised, multicentre, open-label trial to compare DMPA-IM, a copper intrauterine device (IUD), and a levonorgestrel (LNG) implant among African women seeking effective contraception and living in areas of high HIV incidence.

TL;DR: New information increases concerns about DMPA and HIV acquisition risk in women, and data for other hormonal contraceptive methods, including norethisterone enanthate, are largely reassuring.

TL;DR: The role that male partners play in FP/C uptake and use is important in preventing unintended pregnancies and improving family planning policy and service delivery programmes, and how these positive strategies can be incorporated into policy to improve the uptake andUse ofFP/C.

TL;DR: Overall, data do not support an association between use of oral contraceptives and increased risk of HIV acquisition and programs, practitioners, and women urgently need guidance on how to maximize health with respect to avoiding both unintended pregnancy and HIV given inconclusive or limited data for certain HC methods.

TL;DR: Key community and health systems factors that should be considered by policy, program planners and implementers in the design and implementation of family planning and contraceptive services programmes are highlighted to ensure sustained uptake and increased met needs for contraceptive methods and services.